Comparison of the Pharmacokinetics, Safety, and Tolerability of Two Empagliflozin Formulations in Healthy Korean Subjects

Jiang, X; Bae, S; Yoon, DY; Park, SJ; Oh, J; Cho, JY; Yu, KS

Yu, KS (通讯作者)，Seoul Natl Univ, Coll Med & Hosp, Dept Clin Pharmacol & Therapeut, 101 Dae hak ro, Seoul 03080, South Korea.

DRUG DESIGN DEVELOPMENT AND THERAPY, 2023; 17 (): 2137

Abstract

Purpose: Empagliflozin is a sodium-glucose cotransporter 2 inhibitor that is commonly used for the treatment of type 2 diabetes mellitus. As cocrystal......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索